Get informed when a big investor buys or sells
+ FollowOvervalued by 90.9% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $6.92 Billion |
|---|---|
| Enterprise Value | $6.54 Billion |
| Earnings per Share | $-4.83 |
| Beta | -0.21 |
| Outstanding Shares | 79,647,974 |
| P/E Ratio | -16.79 |
|---|---|
| PEG | -101.66 |
| Price to Sales | - |
| Price to Book Ratio | 21.2 |
| Enterprise Value to Revenue | 3264.07 |
| Enterprise Value to EBIT | -15.95 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Based in Paris, France, ABIVAX Société Anonyme is a biopharmaceutical company dedicated to the discovery and optimization of novel drug treatments. Their research and development efforts primarily target inflammatory conditions, infectio...